Development of Smart and Portable Controllable Syringe Pump System for Medical Applications

Due to their efficiency and adaptability, automated applications are consistently gaining popularity around the world. Robotics and their applications as used in a variety of commonplace industries, such as medical applications, require a high level of precision and accuracy. This can be achieved by utilizing automated applications. In this work, the development and design of a regulated injection pump is detailed. The developed prototype is a type of robot that can be utilized in hospitals and other medical facilities. The proposed design is used to pump specific liquid volumes as specified by the user. During liquid pumping, both the fluid’s volume and velocity can be manipulated. Implementation of the proposed system required the development of a complete mechanical system and a controller. The proposed system was implemented successfully, and its operation was deemed satisfactory. According to the results, the accuracy of the system was also satisfactory. Using a flow sensor, the reference value and the measured value acquired from the designed device were compared. Compared to similar devices, the proposed system demonstrated exceptional precision, with an average error rate of less than 1.5%. The proposed model has the advantages of using a commercially available injection syringe and being significantly less expensive than similar devices on the market

Development of Smart and Portable Controllable Syringe Pump System for Medical Applications

Due to their efficiency and adaptability, automated applications are consistently gaining popularity around the world. Robotics and their applications as used in a variety of commonplace industries, such as medical applications, require a high level of precision and accuracy. This can be achieved by utilizing automated applications. In this work, the development and design of a regulated injection pump is detailed. The developed prototype is a type of robot that can be utilized in hospitals and other medical facilities. The proposed design is used to pump specific liquid volumes as specified by the user. During liquid pumping, both the fluid’s volume and velocity can be manipulated. Implementation of the proposed system required the development of a complete mechanical system and a controller. The proposed system was implemented successfully, and its operation was deemed satisfactory. According to the results, the accuracy of the system was also satisfactory. Using a flow sensor, the reference value and the measured value acquired from the designed device were compared. Compared to similar devices, the proposed system demonstrated exceptional precision, with an average error rate of less than 1.5%. The proposed model has the advantages of using a commercially available injection syringe and being significantly less expensive than similar devices on the market

Diagnosis and management of Paget’s disease of bone in adults: A clinical guideline

An evidence-based clinical guideline for the diagnosis and management of Paget's disease of bone (PDB) was developed using GRADE methodology, by a Guideline Development Group (GDG) led by the Paget's Association (UK). A systematic review of diagnostic tests and pharmacological and nonpharmacological treatment options was conducted that sought to address several key questions of clinical relevance. Twelve recommendations and five conditional recommendations were made, but there was insufficient evidence to address eight of the questions posed. The following recommendations were identified as the most important: 1) Radionuclide bone scans, in addition to targeted radiographs, are recommended as a means of fully and accurately defining the extent of metabolically active disease in patients with PDB. 2) Serum total alkaline phosphatase (ALP) is recommended as a first-line biochemical screening test in combination with liver function tests in screening for the presence of metabolically active PDB. 3) Bisphosphonates are recommended for the treatment of bone pain associated with PDB. Zoledronic acid is recommended as the bisphosphonate most likely to give a favorable pain response. 4) Treatment aimed at improving symptoms is recommended over a treat-to-target strategy aimed at normalizing total ALP in PDB. 5) Total hip or knee replacements are recommended for patients with PDB who develop osteoarthritis in whom medical treatment is inadequate. There is insufficient information to recommend one type of surgical approach over another. The guideline was endorsed by the European Calcified Tissues Society, the International Osteoporosis Foundation, the American Society of Bone and Mineral Research, the Bone Research Society (UK), and the British Geriatric Society. The GDG noted that there had been a lack of research on patient-focused clinical outcomes in PDB and identified several areas where further research was needed